Clinical Trial Detail

NCT ID NCT01263782
Title BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

lung non-small cell carcinoma

Therapies

Bevacizumab

Carboplatin + Pemetrexed Disodium

Cixutumumab

Age Groups: adult

No variant requirements are available.